Institute for Molecular Medicine Finland:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Institute for Molecular Medicine Finland - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9409
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Institute for Molecular Medicine Finland (FIMM) is a research institute that conducts research activities in the fields of human genomics and personalized medicine. The institute develops diagnostics, treatment and prevention of common health problems using Finnish clinical and epidemiological study materials. It offers services such as cell line authentication, capillary sequencing, SNP genotyping and CNV analysis, gene expression analysis, assay development and screening format adaptation, secondary assay testing and microarray printing, among others. FIMM’s technology centre offers bioinformatics, digital microscopy and molecular pathology, extracellular vesicles, genotyping, high content imaging and analysis, high throughput biomedicine (htb), IT, metabolomics, sequencing and single cell analytics, among others. The institute provides doctoral training, FIMMPOD Postdoctoral program and other activities. FIMM is headquartered in Helsinki, Finland.

Institute for Molecular Medicine Finland – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
UPM Biochemicals Partners with Institute for Molecular Medicine Finland 10
Labcyte And Institute For Molecular Medicine Finland Partner To Advance Personalized Medicine In Cancer Treatments 11
Labcyte Extends Agreement with Institute for Molecular Medicine Finland 12
Institute for Molecular Medicine Finland – Key Competitors 13
Institute for Molecular Medicine Finland – Key Employees 14
Institute for Molecular Medicine Finland – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Government and Public Interest 16
Nov 15, 2017: New Study Suggests a Role for Gene Regulation in Schizophrenia 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Key Facts 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Molecular Medicine Finland, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
UPM Biochemicals Partners with Institute for Molecular Medicine Finland 10
Labcyte And Institute For Molecular Medicine Finland Partner To Advance Personalized Medicine In Cancer Treatments 11
Labcyte Extends Agreement with Institute for Molecular Medicine Finland 12
Institute for Molecular Medicine Finland, Key Competitors 13
Institute for Molecular Medicine Finland, Key Employees 14

List of Figures
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Institute for Molecular Medicine Finland:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tengasco Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Tengasco Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Tengasco Inc (Tengasco) is an oil and gas exploration and production company that offers oil and gas development and exploration services. The company acquires, explores, produces, extracts, operates, m …
  • Shionogi & Co., Ltd.:企業の戦略・SWOT・財務情報
    Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Microchip Technology Incorporated (MCHP):企業の財務・戦略的SWOT分析
    Microchip Technology Incorporated (MCHP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Factor Therapeutics Ltd (FTT):企業の財務・戦略的SWOT分析
    Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd, is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor …
  • Israel Chemicals Ltd.:企業のM&A・事業提携・投資動向
    Israel Chemicals Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Israel Chemicals Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • MDNA Life Sciences Inc-医療機器分野:企業M&A・提携分析
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test (PCMT) based on the science of mitochondrial DNA (mtDNA) is a tissue-based prostate cancer diagnostics for prostate and o …
  • Einstein Noah Restaurant Group, Inc. (Foodservice):企業の戦略・SWOT・財務情報
    Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • TMX Group Limited (X):企業の財務・戦略的SWOT分析
    TMX Group Limited (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Athersys Inc (ATHX):製薬・医療:M&Aディール及び事業提携情報
    Summary Athersys Inc (Athersys) is a biotechnology company that discovers and develops of novel and proprietary best-in-class therapies in the field of regenerative medicine. Its lead platform, MultiStem, is a patented stem cell product, developed for treating multiple disease indications such as ca …
  • Fibrocell Science Inc (FCSC):医療機器:M&Aディール及び事業提携情報
    Summary Fibrocell Science Inc (Fibrocell Science) is an autologous cell and gene therapy company which discovers and develops therapies for diseases affecting the skin and connective tissue. The company’s product pipeline comprises FCX-007, a lead candidate for the treatment of recessive dystrophic …
  • Envision Healthcare Corp:戦略・SWOT・企業財務分析
    Envision Healthcare Corp - Strategy, SWOT and Corporate Finance Report Summary Envision Healthcare Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • NARI Technology Development Co Ltd (600406):企業の財務・戦略的SWOT分析
    NARI Technology Development Co Ltd (600406) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Baloise Holding Ltd (BALN):企業の財務・戦略的SWOT分析
    Baloise Holding Ltd (BALN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Thornton & Ross Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Thornton & Ross Ltd (Thornton & Ross), a subsidiary of Stada Arzneimittel AG is a supplier of medicines and healthcare products. The company offers over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and semi-solids. Thornton & Ross’ products compris …
  • Godrej Consumer Products Limited:企業の戦略・SWOT・財務情報
    Godrej Consumer Products Limited - Strategy, SWOT and Corporate Finance Report Summary Godrej Consumer Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Osaka Gas Co., Ltd.:戦略・SWOT・企業財務分析
    Osaka Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Osaka Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bayer HealthCare Pharmaceuticals:医療機器:M&Aディール及び事業提携情報
    Summary Bayer HealthCare Pharmaceuticals (Bayer Healthcare), formerly Bayer Schering Pharma AG, a subsidiary of Bayer AG, is the pharmaceutical company that develops, manufactures and markets prescription products in the areas of general medicine and specialty medicine. The company offer prescriptio …
  • Astute Medical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Astute Medical Inc (Astute Medical) is a healthcare service provider that provides diagnostic products. The company offers biomarker products such as nephro check test and astute meter. Its products are used in the field of identifying and validating biomarkers of acute kidney injury through …
  • Kvaerner ASA (KVAER):石油・ガス:M&Aディール及び事業提携情報
    Summary Kvaerner ASA (Kvaerner) is a provider of engineering, procurement and construction (EPC) services to steel substructures, topsides, concrete structures and onshore facilities. Its service portfolio includes project management, front-end engineering and design, detailed engineering, construct …
  • Lear Corporation (LEA):企業の財務・戦略的SWOT分析
    Lear Corporation (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆